Modifiable AHOs Are Prognostic in Testicular Cancer Survivors
Modifiable adverse health outcomes affect overall mortality and cancer mortality in testicular cancer survivors.
Modifiable adverse health outcomes affect overall mortality and cancer mortality in testicular cancer survivors.
Bone marrow infiltration of lymphoma cells is a risk factor for grade 2 or higher infusion-related reactions in B-NHL treated with rituximab.
Guideline implementation strategies did not provide a sufficient improvement in pain-related outcomes for patients with advanced cancer.
A population-based study revealed risk factors for endocrine therapy discontinuation and medication nonadherence in men with breast cancer.
Researchers identified cultural and practical differences among Asian American subgroups that should influence culturally aware counseling for these patients.
Researchers sought to determine if bupriopion improved sexual desire, satisfaction, or fatigue interference with function in women cancer survivors.
Researchers sought to develop and validate a risk score model to predict prognosis for patients with multiple myeloma.
Researchers sought to determine the potential risk of cardiovascular mortality vs risk of disease recurrence in patients with early-stage HL receiving IFRT after ABVD.
Researchers interviewed multiple myeloma patients to determine what factors influence their ability to participate in shared decision-making with their clinicians.
Researchers sought to determine the accuracy of established tools in predicting the risk of cardiovascular events in patients with CML receiving TKIs.